MS-OMICS ApS: Financial statements 2023
CVR: 36070374
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
MS-OMICS ApS (CVR 36070374) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 15,391,185 and a net result of DKK 423,328 compared with DKK -155,271 the year before. That is an increase of 43.7% compared with the year before. Equity in the 2023 report amounted to DKK 21,618. The solvency ratio was 0.1%. The company had 13 employees in the financial year.
- Gross Profit
- DKK 15,391,185
- Profit/Loss
- DKK 423,328
- Equity
- DKK 21,618
- Total Assets
- DKK 18,691,105
- Employees
- 13
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 15.4 mio. | 423 t. | 22 t. | 13 |
| 2022 | - | 10.7 mio. | -155 t. | -402 t. | 11 |
| 2021 | - | 7.3 mio. | 419 t. | 70 t. | 10 |
| 2020 | - | 3.5 mio. | -1.3 mio. | -349 t. | 7 |
| 2019 | - | 2.6 mio. | -45 t. | 418 t. | 5 |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
MS-OMICS ApS has published its annual report for 2022. Gross profit came to DKK 10,713,930, and the net result was DKK -155,271.
About MS-OMICS ApS
MS-OMICS ApS is a Danish company of the type Anpartsselskab based in Vedbæk, founded in 2014. The company is registered under the industry Anden teknisk rådgivning. The management consists of Anders Mohr Christensen. The company is owned by Clinical-Microbiomics A/S. The company has 6 employees (2018). In 2025, the company reported a gross profit of DKK 16,799,037 and a net result of DKK 806,990 compared with DKK 2,341,741 the year before. Equity in the 2025 report amounted to DKK 3,170,348.